Physician profile
Steven Waldman
NPI 1366608499
$160,519.15
in general payments reported to CMS, 2019-2025
7 companies · $46K in 2025
The $46K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $8,642 · 2021: $5,537 · 2022: $372 · 2023: $74K · 2024: $26K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $142K · Consulting Fee: $3,000 · Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $141,750.00 |
| Consulting Fee | $3,000.00 |
| Food and Beverage | $803.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $142,468.35 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $12,405.92 | 2019-2022 | |
| Galderma Laboratories, L.P. | $5,345.34 | 2019-2024 | |
| Merz North America, INC. | $116.78 | 2019-2020 | |
| Mentor Worldwide LLC | $98.05 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Medtronic, INC. | $43.78 | 2022 | |
| Baxter Healthcare | $40.93 | 2021-2025 | Tisseel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Waldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.